Evidence map›Paper›PMID 34255684›Full record

ArticleJMIR medical informatics2021

Machine Learning Methods for the Diagnosis of Chronic Obstructive Pulmonary Disease in Healthy Subjects: Retrospective Observational Cohort Study.

Shigeo Muro, Masato Ishida, Yoshiharu Horie, Wataru Takeuchi, Shunki Nakagawa, Hideyuki Ban, Tohru Nakagawa, Tetsuhisa Kitamura

Abstract read
In one paragraph

Article in JMIR medical informatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Investigation of time profile of FEVScientific reports · 2023
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shigeo MuroDepartment of Respiratory Medicine, Nara Medical University, Nara, Japan.ORCID https://orcid.org/0000-0001-7452-9191
Masato IshidaDepartment of Respiratory and Immunology, Medical, AstraZeneca KK, Osaka, Japan.ORCID https://orcid.org/0000-0001-9719-7863
Yoshiharu HorieDepartment of Data Science, Medical, AstraZeneca KK, Osaka, Japan.ORCID https://orcid.org/0000-0003-2609-2495
Wataru TakeuchiCenter for Technology Innovation-Artificial Intelligence, Research & Development Group, Hitachi, Ltd, Tokyo, Japan.ORCID https://orcid.org/0000-0003-2515-1289
Shunki NakagawaCenter for Technology Innovation-Artificial Intelligence, Research & Development Group, Hitachi, Ltd, Tokyo, Japan.ORCID https://orcid.org/0000-0001-7933-668X
Hideyuki BanCenter for Technology Innovation-Artificial Intelligence, Research & Development Group, Hitachi, Ltd, Tokyo, Japan.ORCID https://orcid.org/0000-0002-8785-0950
Tohru NakagawaHitachi Health Care Center, Hitachi, Ltd, Ibaraki, Japan.ORCID https://orcid.org/0000-0003-4129-3033
Tetsuhisa KitamuraDivision of Environmental Medicine and Population Sciences, Department of Social and Environmental Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.ORCID https://orcid.org/0000-0003-0107-0580

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAirflow limitation is a critical physiological feature in chronic obstructive pulmonary disease (COPD), for which long-term exposure to noxious substances, including tobacco smoke, is an established risk. However, not all long-term smokers develop COPD, meaning that other risk factors exist.

objectiveThis study aimed to predict the risk factors for COPD diagnosis using machine learning in an annual medical check-up database.

methodsIn this retrospective observational cohort study (ARTDECO [Analysis of Risk Factors to Detect COPD]), annual medical check-up records for all Hitachi Ltd employees in Japan collected from April 1998 to March 2019 were analyzed. Employees who provided informed consent via an opt-out model were screened and those aged 30 to 75 years without a prior diagnosis of COPD/asthma or a history of cancer were included. The database included clinical measurements (eg, pulmonary function tests) and questionnaire responses. To predict the risk factors for COPD diagnosis within a 3-year period, the Gradient Boosting Decision Tree machine learning (XGBoost) method was applied as a primary approach, with logistic regression as a secondary method. A diagnosis of COPD was made when the ratio of the prebronchodilator forced expiratory volume in 1 second (FEV

resultsOf the 26,101 individuals screened, 1213 met the exclusion criteria, and thus, 24,815 individuals were included in the analysis. The top 10 predictors for COPD diagnosis were FEV

conclusionsUsing a machine learning model in this longitudinal database, we identified a number of parameters as risk factors other than smoking exposure or lung function to support general practitioners and occupational health physicians to predict the development of COPD. Further research to confirm our results is warranted, as our analysis involved a database used only in Japan.

Indexed as

airflow limitationchronic obstructive pulmonary diseaseGradient Boosting Decision Treelogistic regressionmedical check-up

Identifiers

PMID34255684
PMCPMC8293159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.